Australia’s PBS Lists Four Adalimumab Biosimilars
‘A-Flag’ Allows Substitution For Humira As Well As Between Biosimilars
Four different biosimilar versions of Humira will be listed on Australia’s PBS from the start of April, with the country’s “a-flagging” mechanism allowing substitution for the brand and between adalimumab biosimilars.
